Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccine for modulating between T1 and T2 immune responses

Vaccine for modulating between T1 and T2 immune responses

US Patent 8198400 · Granted Jun 12, 2012

Estimated economic value: $3,396,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mucinous glycoprotein (MUC-1) vaccine2015
Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine2015
Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine2014
Vaccine for modulating between T1 and T2 immune responses2013
Vaccine for modulating between T1 and T2 immune responses2013
Vaccine for modulating between T1 and T2 immune responses2013
Vaccine for modulating between T1 and T2 immune responses2013
Lipid A and other carbohydrate ligand analogs2012
Lipid A and other carbohydrate ligand analogs2012
Lipid A and other carbohydrate ligand analogs2010
Lipid A and other carbohydrate ligand analogs2010
Methods of detecting T-cell activation2003